Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group LSE:RENE London Ordinary Share GB00B0DZML60 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 1.75p 1.70p 1.80p 1.75p 1.75p 1.75p 987,644 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -18.2 -0.5 - 55.29

Reneuron Share Discussion Threads

Showing 5426 to 5448 of 5450 messages
Chat Pages: 218  217  216  215  214  213  212  211  210  209  208  207  Older
DateSubjectAuthorDiscuss
26/7/2017
14:03
No placing; Shake up the register and wake up the dead.
norbus
25/7/2017
18:34
New joint broker = placing?
127tolmers
05/7/2017
18:30
Out all day and missed one of the few up days.
dickbush
05/7/2017
17:21
Good god. It's going up. 0.4p a share up on my last purchase.
yachtmaster2
04/7/2017
08:51
Thanks,algernon2 A very professional and positive presentation. However, he and the company seem to continue to have a major credibility problem-as judged by the share price. Despite record highs for the stockmarket, the share price is at an all-time low with holders, apparently, willing to sell no matter what the bid price.
dickbush
03/7/2017
20:59
"It's 'all systems go' as ReNeuron gears up for Phase III stroke disability study" hTTps://www.youtube.com/watch?v=QJaKk3F-TQs
algernon2
30/6/2017
10:22
Hi Algernon.
fredd1eboy
30/6/2017
10:18
Hello Freddie.
algernon2
29/6/2017
18:24
Seems like all tech shares are being hit by a bubble in some... D
dennisbergkamp
29/6/2017
18:21
Agreed, Verger. I'm not sure, as the presentation claims, that they are ahead of competition in all of their areas of interest. However, it was a good presentation, I thought, although my level of expertise in biotec is minimal. The shares are my speculation in an exciting area. I know what the downside is!
dickbush
29/6/2017
18:06
Or you could say that no value is being given to its potential. This is silly.
verger
29/6/2017
17:35
Shares being valued at its cash. No value, therefore, being assigned to all the clinical work that has taken place so far.
dickbush
29/6/2017
10:22
'Results' are a list of projects being worked on. The real news - or results really - come at times when they discover something or someone offers money. The consequence of today's RNS , so far, is that the share price trajectory is maintaining its 'going down the drain' path.Of course that can change suddenly, & I certainly hope it will .
dogwalker
29/6/2017
09:54
Any thoughts on results today? Missed the presentation too ;-( D
dennisbergkamp
28/6/2017
17:22
I know good after bad etc.
yachtmaster2
28/6/2017
17:21
I bought a lot for a very small amount of money yesterday afternoon. Went through as a sell
yachtmaster2
28/6/2017
16:44
ReNeuron CFO Michael Hunt will be presenting to investors at the Proactive One2One Forum on the evening of 13th July in London. For details and registration, click here: https://tinyurl.com/ya62szgf
aim_trader
26/6/2017
13:45
Just bought a few at 1.799 pence at 13.35 for those interested to see if it later indicated it was a buy or a sell.I see plenty of potential upside medium term at this price.Here's to us Freddie and our pension fund. "Per Ardua Ad Astra" and chocks away! Edit: appears to be indicated as a sell on all the share platforms I looked at just now.
algernon2
19/6/2017
19:36
Another piece of the jigsaw.I doubt it'll be catalyst for a sustained rise in the share price ....more likely to see it meander at 2p for while
audigger
19/6/2017
10:27
Huge potential here, but the market has been bitten to many times by jam tomorrow AIM companies. Although RENE have cash now, its not enough to take these therapies through to commercialisation, even if they do get approval. That's the problem with the share price. I'll continue on the side lines for the time being GLA.
johnb5
19/6/2017
09:47
FDA Approval is huge. Healthcare in the US is a huge business as its mainly private and paid out for through the huge insurance premiums they have to pay. This really should be flying / taken out by a bigger player. D.
dennisbergkamp
19/6/2017
09:30
It looks like everyone's on early hols across the entire market. Sleepy volumes everywhere.
small crow
19/6/2017
09:20
FDA Approval for their hRPC ophthamology formulation and still not much activity... Incredible!
dennisbergkamp
Chat Pages: 218  217  216  215  214  213  212  211  210  209  208  207  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20170727 00:54:13